Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Drobniewski

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 27, 2016
Whole genome sequencing of Mycobacterium tuberculosis for detection of drug resistance: a systematic reviewD Papaventsis, N Casali, I Kontsevaya, et al.
The Journal of Infectious Diseases|May 1, 1994
Drug resistance is not the principal barrier to effective control of tuberculosis in ZambiaF Drobniewski, G Kahenya, R Msiska, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 13, 2003
European recommendations on surveillance of antituberculosis drug resistanceV Schwoebel, C.S.B. Lambregts, M.L. Moro, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 2, 2016
True rifampicin resistance missed by the MGIT: prevalence of this pheno/genotype in the UK and Ireland after 18 month surveillanceX Gonzalo, P Claxton, T Brown, et al.
Thorax|August 30, 2002
A national study of clinical and laboratory factors affecting the survival of patients with multiple drug resistant tuberculosis in the UKF Drobniewski, I Eltringham, C Graham, et al.
European Journal of Public Health|September 17, 2004
A framework and toolkit for capturing the communicable disease programmes within health systems: tuberculosis control as an illustrative exampleR A Atun, N Lennox-Chhugani, F Drobniewski, et al.
Lancet (London, England)|March 4, 1995
Intestinal mycobacteria in African AIDS patientsC L Pankhurst, N Luo, P Kelly, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 25, 2005
Multidrug-resistant tuberculosis in Russia: clinical characteristics, analysis of second-line drug resistance and development of standardized therapyY Balabanova, M Ruddy, J Hubb, et al.
Respiratory Research|March 25, 2006
The Directly Observed Therapy Short-Course (DOTS) strategy in Samara Oblast, Russian FederationY Balabanova, F Drobniewski, I Fedorin, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 16, 2000
Tuberculous meningitisG Thwaites, T T Chau, N T Mai, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 27, 2016
Whole genome sequencing of Mycobacterium tuberculosis for detection of drug resistance: a systematic reviewD Papaventsis, N Casali, I Kontsevaya, et al.
The Journal of Infectious Diseases|May 1, 1994
Drug resistance is not the principal barrier to effective control of tuberculosis in ZambiaF Drobniewski, G Kahenya, R Msiska, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 13, 2003
European recommendations on surveillance of antituberculosis drug resistanceV Schwoebel, C.S.B. Lambregts, M.L. Moro, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 2, 2016
True rifampicin resistance missed by the MGIT: prevalence of this pheno/genotype in the UK and Ireland after 18 month surveillanceX Gonzalo, P Claxton, T Brown, et al.
Thorax|August 30, 2002
A national study of clinical and laboratory factors affecting the survival of patients with multiple drug resistant tuberculosis in the UKF Drobniewski, I Eltringham, C Graham, et al.
European Journal of Public Health|September 17, 2004
A framework and toolkit for capturing the communicable disease programmes within health systems: tuberculosis control as an illustrative exampleR A Atun, N Lennox-Chhugani, F Drobniewski, et al.
Lancet (London, England)|March 4, 1995
Intestinal mycobacteria in African AIDS patientsC L Pankhurst, N Luo, P Kelly, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 25, 2005
Multidrug-resistant tuberculosis in Russia: clinical characteristics, analysis of second-line drug resistance and development of standardized therapyY Balabanova, M Ruddy, J Hubb, et al.
Respiratory Research|March 25, 2006
The Directly Observed Therapy Short-Course (DOTS) strategy in Samara Oblast, Russian FederationY Balabanova, F Drobniewski, I Fedorin, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 16, 2000
Tuberculous meningitisG Thwaites, T T Chau, N T Mai, et al.
Pageof 8